Asia-Pacific Osteoarthritis Therapeutics Market Demand And Growth Analysis 2022-28

The asia-pacific osteoarthritis therapeutics market size was valued at USD 7,500 million in 2021, growing at a CAGR of 8.0% from 2022 to 2028. A recent development in the realm of treating OA may give people who experience associated pain symptoms better joint mobility. Chondroitin sulfate was discovered to dramatically lessen discomfort and increase hand mobility in those with osteoarthritis. Two objectives of osteoarthritis treatment are pain alleviation and improved functional status. To get the best results, patients should receive both pharmacologic and non-pharmacologic care. Even though osteoarthritis seldom results in death, it can significantly affect a person's quality of life. Many folks choose to skip work or their favorite pastimes when their pain flares up. The Arthritis Foundation estimates that the illness results in more than 25.5 million outpatient visits annually.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/asia-pacific-osteoarthritis-therapeutics-market/

Asia-Pacific Osteoarthritis Therapeutics Market:
Individuals are more likely to develop OA as a result of sedentary lifestyles, poor dietary habits, and increased rates of obesity and blood sugar. This is one of the main driving forces behind the osteoarthritis therapies market expansion, along with the rising senior population, which is more sensitive to such illnesses. In addition, the simple availability of MRI images is a significant growth-promoting element. In addition, the introduction of analgesic medications and the development of imaging biomarkers based on radiographic features are fostering market expansion. The market is also being driven by increased spending on enhancing healthcare infrastructure as well as increasing investments in research and development (R&D) activities to introduce new diagnostics and biomarkers.

Asia-Pacific Osteoarthritis Therapeutics Market Segmentation:
1) By Disease Type: Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, Others.
2) By Drug Class: Viscosupplementation Agents, NSAIDs, Analgesics, Corticosteroids, Others.
3) By Route of Administration: Oral, Topical, Parenteral.
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=53448

Asia-Pacific Osteoarthritis Therapeutics Market Regional Analysis:
The market for osteoarthritis treatments in Asia Pacific is anticipated to expand at a CAGR of 9.5% over the forecast period. A sizable senior population base and rising awareness of orthopaedic problems in the area are two important drivers of market expansion. According to the United Nations (UN), the proportion of people in South-Eastern and Eastern Asia who are 65 or older has nearly doubled, going from 6.5% in 1990 to 12% in 2020. One of the main causes of chronic disability in older persons is osteoarthritis. Along with other risk factors, aging favors the onset of osteoarthritis. The imbalance between catabolic and anabolic activity in the joint that characterizes the disease is probably brought on by aging. As a result, one of the key factors contributing to the increase in osteoarthritis cases in the area, which in turn is fueling market expansion, is a sizable aging population base.

Major players working in the asia-pacific osteoarthritis therapeutics market are Pfizer, Inc., Novartis AG, Sanofi SA, Anika Therapeutics, Inc., Flexion Therapeutics, Bayer AG, Sorrento Therapeutics.

Contact:
Mr. Satya
Precision Business Insights | Toll-Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Website: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.